NPS Pharmaceuticals, Inc. (NPSP) Reports Q3 Loss of $0.14, Sales Top Expectations
Tweet
Share
E-mailGet Alerts NPSP Hot Sheet
Join SI Premium – FREE
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) reported Q3 EPS of ($0.14), $0.03 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $24.6 million versus the consensus estimate of $24.53 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
- Range Impact, Inc. (RNGE) Reports Q2 Loss of $0.02
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
